Effect of CT simulation positioning and three-dimensional conformal radiotherapy combined with TP regimen on serum SCC level and prognosis of advanced esophageal cancer
10.3760/cma.j.cn431274-20200928-01342
- VernacularTitle:CT模拟定位三维适形放疗联合TP方案对晚期食管癌患者血清SCC水平及预后的影响
- Author:
Tuerdi GULINAER
1
;
Chengbin ZHU
;
Hui ZHAO
;
Yi SUN
Author Information
1. 新疆维吾尔自治区人民医院放疗中心，乌鲁木齐 830001
- Keywords:
Esophageal neoplasms;
Conformal radiotherapy, three-dimensional;
Tomography;
Paclitaxel;
Cisplatin;
SCC antigen
- From:
Journal of Chinese Physician
2021;23(12):1838-1841,1846
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effects of CT simulation positioning and three-dimensional conformal radiotherapy combined with regimen of paclitaxel and cisplatin (TP) on serum squamous cell carcinoma antigen (SCC) level and prognosis in patients with advanced esophageal cancer.Methods:A total of 80 cases of advanced esophageal cancer patients in People′s Hospital of Xinjiang Uygur Autonomous Region from June 2016 to October 2017 were selected and randomly divided into treatment group and control group, with 40 cases in each group. The control group was treated with CT simulation positioning three-dimensional combined cisplatin and Docetaxel, and the treatment group was treated with CT simulation positioning three-dimensional combined TP regimen. The clinical efficacy, tumor marker levels [serum SCC, carcinoembryonic antigen (CEA), carbohydrate antigen-199 (CA-199), human cytokeratin 21-1 fragment (CYFRA21-1)], Karnofsky functional status (KPS) score, Quality of Life(QOL) score, progression free survival period and incidence of adverse reactions were compared between the two groups.Results:After treatment, the total effective rate in the treatment group was 70.00%, which was significantly higher than 55.00% in the control group ( P<0.05); the levels of serum SCC, CEA, CA-199 and CYFRA21-1 in the two groups after treatment were significantly lower than those before treatment ( P<0.05), and those in the treatment group were significantly lower than those in the control group ( P<0.05); after treatment, the QOL and KPS scores in the two groups were significantly higher than those before treatment ( P<0.05), and the scores in the treatment group were significantly higher than those in the control group ( P<0.05); The progression free survival time in the treatment group was significantly longer than that in the control group ( P<0.05); The incidence of adverse reactions in the treatment group was 15.00%, which had no significant difference compared with 25.00% in the control group ( P>0.05). Conclusions:CT simulation positioning three-dimensional combined with TP regimen in the treatment of advanced esophageal cancer has obvious effect, can effectively reduce the level of tumor markers, improve the patient′s physical function and quality of life, improve prognosis , and does not increase the survival rate of adverse reactions, which is safe and effective.
